Karyopharm Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. 

CEO
Richard A. Paulson
CEORichard A. Paulson
Employees
279
Employees279
Headquarters
Newton, Massachusetts
HeadquartersNewton, Massachusetts
Founded
2008
Founded2008
Employees
279
Employees279

KPTI Key Statistics

Market cap
47.90M
Market cap47.90M
Price-Earnings ratio
-0.37
Price-Earnings ratio-0.37
Dividend yield
Dividend yield
Average volume
93.93K
Average volume93.93K
High today
$5.86
High today$5.86
Low today
$5.52
Low today$5.52
Open price
$5.81
Open price$5.81
Volume
50.76K
Volume50.76K
52 Week high
$18.00
52 Week high$18.00
52 Week low
$3.51
52 Week low$3.51

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.